Sears, T.K.; Wang, W.; Drumm, M.; Unruh, D.; McCord, M.; Horbinski, C.
F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma. Cancers 2025, 17, 834.
https://doi.org/10.3390/cancers17050834
AMA Style
Sears TK, Wang W, Drumm M, Unruh D, McCord M, Horbinski C.
F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma. Cancers. 2025; 17(5):834.
https://doi.org/10.3390/cancers17050834
Chicago/Turabian Style
Sears, Thomas K., Wenxia Wang, Michael Drumm, Dusten Unruh, Matthew McCord, and Craig Horbinski.
2025. "F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma" Cancers 17, no. 5: 834.
https://doi.org/10.3390/cancers17050834
APA Style
Sears, T. K., Wang, W., Drumm, M., Unruh, D., McCord, M., & Horbinski, C.
(2025). F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma. Cancers, 17(5), 834.
https://doi.org/10.3390/cancers17050834